Filing Summary
Business Context and Reporting Period
This Form 8-K was filed by DMY Technology Group, Inc. IV, a special purpose acquisition company, with an event date of March 9, 2021. The request identifies Planet Labs PBC, but Planet Labs is not the registrant named in the filing.
Key Financial and Capitalization Metrics
- IPO: 34.5 million units sold at $10.00 per unit, generating $345.0 million of gross proceeds. The amount includes 4.5 million units issued upon full exercise of the underwriters’ over-allotment option.
- Unit composition: Each unit included one share of Class A common stock and one-fifth of a redeemable warrant.
- Warrants: Each whole IPO warrant is exercisable for one share of Class A common stock at $11.50 per share, subject to adjustment.
- Private placement: 5,933,333 warrants were sold to the sponsor at $1.50 per warrant, generating $8.9 million of gross proceeds.
- Trust account: $345.0 million was deposited into a U.S.-based trust account. This comprised $338.1 million of IPO proceeds, including a $12.075 million deferred underwriting discount, and $6.9 million from the private placement warrants.
- The filing text does not provide operating revenue, profit, cash flow, margins, debt, or liquidity metrics beyond the IPO and trust-account proceeds.
Changes Versus the Prior Comparable Period
The filing reports the consummation of the IPO and private placement; it does not provide a prior comparable period or operating-period financial results for comparison.
Outlook, Risks, Contingencies, and Unusual Items
- The filing does not provide business-combination guidance, operating forecasts, or management commentary on future performance.
- As a SPAC, the proceeds are held in trust pending a qualifying business combination or other permitted use under the company’s governing terms.
- Key unusual items include the deferred underwriting discount, the private placement warrants, and the warrant exercise price of $11.50 per share.
- Potential investor considerations include redemption rights, the terms and dilution effects of public and private warrants, and the eventual target-company transaction; specific terms are not detailed in the provided text.
Important Facts to Verify
- Confirm that the applicable registrant is DMY Technology Group, Inc. IV rather than Planet Labs PBC.
- Review Exhibit 99.1 for the audited balance sheet as of March 9, 2021.
- Verify the $345.0 million trust-account balance and the composition of deposited proceeds.
- Review the IPO prospectus and warrant agreements for redemption provisions, adjustment mechanisms, and dilution.
- Confirm any subsequent business combination, redemption activity, or changes to the trust account after the filing date.